Login

The 2022 Dining Service Contest by Global-Dining, Inc. highlights essential insights for restaurant owners, focusing on managing closure rates. 00:10:00

Share On Facebook Share On Twitter

Kozo Hasegawa. CEO at Global-Dining, Inc

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
About Addnode Group | Johan Andersson, CEO, Addnode Group AB (publ)ANOD B:STO
00:10:00
Exploring the Fusion of Music and Life Experiences
00:10:00
ChannelX interviews Brent Bellm, CEO of BigCommerce, shedding light on the company's strategies and future endeavors.|Brent is the Chief Executive Officer of BigCommerce.
00:10:00
Avaya CEO Jim Chirico's Interview with CNN's First Move | Donald Bugos , CEO, Communications Systems Inc VC9:BER
00:10:00
San Jose Lithium Project: Key Insights and Strategic Partnerships
00:10:00
Kavango Resources: Exploring Base Metals in Botswana's Kalahari Suture Zone
00:10:00
Michael Granoff on Global Financial Trends and India's Economic Progress
00:10:00
Navigating Challenges in the Pensions Market: Insights from Hilltop's CEO Derek Kelly
00:10:00
The Importance of Estate Planning and Family Mission Statements | Sharon K. Weaver, President, Mission Financial Planning.
00:10:00
"Innovation, Technology, and AI: Strategic Investment Positioning for Capturing Future Growth Opportunities with BBLAM's Industry Experts"
00:00:00
Ulrich von Andrian Mallinckrodt Professor of Immunopathology at Harvard Medical School| Understanding Immune Cell Migration
00:10:00
AquaTech: Innovating Solutions for Global Water Scarcity

© 2026 Nehu